Amit Sachdev, Chief Officer of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $28.4M. The latest trade was on 02/25.

AS

AS

Amit Sachdev

EVP Chief Patient & Ext Af Off

Company

Vertex Pharmaceuticals VRTX

First filing

23/02/03

Trades

51 trades

Buys / sales

0 / 16

12-month net buying

−$28.4M

Last trade

02/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/25	02/26	1,846 sh	$486.35	$897,802.1	−3.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/19	02/23	58,613 sh8 trades	$468.83avg.	$27,479,583.09	−49.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/05/15	24/05/17	32 sh	$430.93	$13,789.76	−0.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/26	24/02/27	3,004 sh	$425.70	$1,278,802.8	−5.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/21	24/02/23	3,191 sh	$421.77	$1,345,868.07	−5.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/20	24/02/21	4,254 sh	$420.79	$1,790,040.66	−6.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/12	24/02/13	3,222 sh	$420.24	$1,354,013.28	−4.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/11/15	23/11/17	35 sh	$369.92	$12,947.2	−0.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/08/10	23/08/14	10,031 sh	$350.00	$3,510,850	−14.6%